Page 12 - 2021 Taiwan Food and Drug Administration Annual Report
P. 12

Section 1                                            RI  6HFUHWDULDW   2൶FH  RI  3HUVRQQHO   2൶FH  RI 
                                                         $FFRXQWLQJ   2IILFH  RI  6HUYLFH  (WKLFV   DQG 
    Organizational Framework                             2IILFH  RI  ,QIRUPDWLRQ  0DQDJHPHQW   WR  DV-
                                                         sist in administrative management (Figure
        /HG  E\  WKH  'LUHFWRU *HQHUDO  7)'$  LV               $OVR   7)'$  KDV  WZR  7DVN  )RUFHV   L H  
    composed of two Deputy Director-Gener-               Factory for Controlled Drugs and Decision
    DOV   RQH  &KLHI  6HFUHWDU\   DQG  VHYHQ  EXVLQHVV   Support Center) to provide professional in-
    units. Including: Division of Planning and           IRUPDWLRQ   JHWWLQJ  SURIHVVLRQDO  DVVLVWDQFHV 
    5HVHDUFK  'HYHORSPHQW   ZKLFK  LV  UHVSRQVL-         from consultation units such as Taiwan Drug
    EOH  IRU  SODQQLQJ  DQG  PDQDJHPHQW   WHFKQLFDO      Relief Foundation and the Center for Drug
    SODQQLQJ  PDQDJHPHQW   LQWHUQDWLRQDO  FRRS-          (YDOXDWLRQ  7DLZDQ 
    HUDWLRQ   OHJDO  V\VWHP   FRQVXPHU  SURWHFWLRQ  
    HWF    'LYLVLRQ  RI  )RRG  6DIHW\   'LYLVLRQ  RI     Section 2
    0HGLFLQDO 3URGXFWV  'LYLVLRQ RI 0HGLFDO 'H-
    YLFHV  DQG  &RVPHWLFV   DV  ZHOO  DV  'LYLVLRQ  RI   Administrative Goals
    &RQWUROOHG  'UXJV   DUH  UHVSRQVLEOH  IRU  SURG-
    XFWV PDQDJHPHQW  SROLFLHV  DQG UHOHYDQW UHJ-             TFDA sets the administrative goals and
    ulations of their managed products; Division         focuses based on the administrative poli-
    of Quality Compliance and Management is              cies of Executive Yuan and administrative
    responsible for laboratory management and            programs of MOHW along with the budget
    DXWKHQWLFDWLRQ   PDQXIDFWXUHUV  PDQDJHPHQW           SODQV   FXUUHQW  GHYHORSPHQW  KLJKOLJKWV   DQG 
    and inspection of pharmaceutical and cos-            VRFLDO  QHHGV  RQ  IRRG   PHGLFLQDO  SURGXFWV  
    PHWLF  SURGXFWV   DQG  LQVSHFWLRQ  RI  KXPDQ  RU-    and cosmetics management in 2020.
    gan bank; Division of Research and Analysis          I. Enhance the management of the life cycle
    LV UHVSRQVLEOH IRU WKH WHVWLQJ RI IRRG  PHGLFL-
    QDO  SURGXFWV   DQG  FRVPHWLFV   PHWKRGRORJLFDO         RI  IRRG   PHGLFLQH   PHGLFDO  GHYLFHV   DQG 
    GHYHORSPHQW  DQG  HYDOXDWLRQ   SKDUPDFRSHLD             FRVPHWLF  WR  PDLQWDLQ  WKH  K\JLHQH   VDIHW\  
    editing and compilation; TFDA also sets 3               and quality and create a safe environment
    'LVWULFW  &HQWHUV   1RUWK   &HQWUDO   DQG  6RXWK        for consumption.
    which are responsible for laboratory testing         II. Strengthen source control management
    RI  LPSRUWHG  IRRG   PHGLFLQDO  SURGXFWV   DQG          DQG  WUDFHDELOLW\  V\VWHP   DQG  LPSOHPHQW 
    cosmetics; as well as distribution exam-                audits and border inspections to improve
    inations and inspections. In addition to the            the sound quality monitoring system.
    EXVLQHVV  GLYLVLRQV   ZH  KDYH  DOVR  HVWDEOLVKHG    III. Reinforce international harmonization of
    ILYH  DGPLQLVWUDWLYH  XQLWV   LQFOXGLQJ  2IILFH         ODZV  DQG  UHJXODWLRQV   GHYHORS  LQVSHFWLRQ 
                                                            FDSDFLW\  LPSURYH WKH LOOHJDO GUXJV LQVSHF-

10
   7   8   9   10   11   12   13   14   15   16   17